Cargando…

No association between triple-negative breast cancer and prognosis of patients receiving breast-conserving treatment

The role of triple-negative breast cancer (TNBC) in breast-conserving treatment is controversial. The present study aimed at evaluating the prognosis of patients with TNBC following breast-conserving treatment (BCT) within 5 years. The present study investigated a cohort of 757 patients with early s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mu, Lan, Liu, Yuxiang, Xiao, Meng, Liu, Weise, Liu, Miao, Wang, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5727599/ https://www.ncbi.nlm.nih.gov/pubmed/29250179 http://dx.doi.org/10.3892/ol.2017.7251

Ejemplares similares

Breast-Conserving Surgery in Triple-Negative Breast Cancer: A Retrospective Cohort Study
por: Zhang, Hengle, et al.
Publicado: (2023)

Neoadjuvant Chemotherapy Combined with Breast-Conserving Surgery in the Treatment of Triple-Negative Breast Cancer
por: Zhang, Xiaoyu, et al.
Publicado: (2022)

Local Treatment of Triple-Negative Breast Cancer: Is Mastectomy Superior to Breast-Conserving Surgery?
por: Di Leone, Alba, et al.
Publicado: (2023)

Triple-negative breast cancer: current treatment strategies and factors of negative prognosis
por: Baranova, Anna, et al.
Publicado: (2022)

Prognosis of selected triple negative apocrine breast cancer patients who did not receive adjuvant chemotherapy
por: Montagna, Emilia, et al.
Publicado: (2020)

Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer
por: Qiu, Jingdan, et al.
Publicado: (2016)

Correlation between the Warburg effect and progression of triple-negative breast cancer
por: Liu, Shaojun, et al.
Publicado: (2023)

Is breast conservation superior to mastectomy in early stage triple negative breast cancer?
por: Saifi, Omran, et al.
Publicado: (2022)

Clinical features and prognosis of triple-negative breast cancer
por: Sanz, M Izquierdo, et al.
Publicado: (2009)

T-cadherin is associated with prognosis in triple-negative breast cancer
por: Kong, De-Di, et al.
Publicado: (2017)

Characteristics of recurrence, predictors for relapse and prognosis of rapid relapse triple-negative breast cancer
por: Cai, Shuang-Long, et al.
Publicado: (2023)

Down-regulated FST expression is involved in the poor prognosis of triple-negative breast cancer
por: Liu, Sainan, et al.
Publicado: (2021)

Ki67 as a predictor of poor prognosis in patients with triple-negative breast cancer
por: LI, HAITAO, et al.
Publicado: (2015)

Identification of necroptosis-related subtypes and prognosis model in triple negative breast cancer
por: Pu, Shengyu, et al.
Publicado: (2022)

Local treatment for triple-negative breast cancer patients undergoing chemotherapy: breast-conserving surgery or total mastectomy?
por: Guo, Leqian, et al.
Publicado: (2021)

Update on triple-negative breast cancer: prognosis and management strategies
por: Brouckaert, Olivier, et al.
Publicado: (2012)

An EMT-Related Gene Signature to Predict the Prognosis of Triple-Negative Breast Cancer
por: Zhang, Bo, et al.
Publicado: (2023)

Stratification of Prognosis of Triple-Negative Breast Cancer Patients Using Combinatorial Biomarkers
por: Yue, Yong, et al.
Publicado: (2016)

High expression of microRNA-454 is associated with poor prognosis in triple-negative breast cancer
por: Cao, Zhi-Gang, et al.
Publicado: (2016)

Tumor infiltrating lymphocytes in triple negative breast cancer receiving neoadjuvant chemotherapy
por: Castaneda, Carlos A, et al.
Publicado: (2016)

Dissecting the heterogeneity of the alternative polyadenylation profiles in triple-negative breast cancers
por: Wang, Lei, et al.
Publicado: (2020)

Prospects of Immunotherapy for Triple-Negative Breast Cancer
por: Qiu, Dan, et al.
Publicado: (2022)

The relationship between nuclear factor (NF)-κB family gene expression and prognosis in triple-negative breast cancer (TNBC) patients receiving adjuvant doxorubicin treatment
por: Kim, Ji-Yeon, et al.
Publicado: (2016)

The role of BRCA status on prognosis in patients with triple-negative breast cancer
por: Xie, Yuxin, et al.
Publicado: (2017)

Effects of BRCA Germline Mutations on Triple-Negative Breast Cancer Prognosis
por: Pogoda, Katarzyna, et al.
Publicado: (2020)

Triple-Negative Breast Cancer Histological Subtypes with a Favourable Prognosis
por: Cserni, Gábor, et al.
Publicado: (2021)

Immunotherapy Treatment for Triple Negative Breast Cancer
por: Berger, Elizabeth R., et al.
Publicado: (2021)

Immunotherapy for the Treatment of Triple-Negative Breast Cancer
por: Tolaney, Sara M., et al.
Publicado: (2022)

Impact of Triple-Negative Breast Cancer Phenotype on Prognosis in Patients with Stage I Breast Cancer
por: Kim, Jeong Eun, et al.
Publicado: (2012)

B7-H4 overexpression contributes to poor prognosis and drug-resistance in triple-negative breast cancer
por: Wang, Ling, et al.
Publicado: (2018)

Target Analysis and Mechanism of Podophyllotoxin in the Treatment of Triple-Negative Breast Cancer
por: Zhang, Wenfeng, et al.
Publicado: (2020)

MRI-based radiomics approach for the prediction of recurrence-free survival in triple-negative breast cancer after breast-conserving surgery or mastectomy
por: Zhao, Jingwei, et al.
Publicado: (2023)

Clinicopathological characteristics and prognosis of metaplastic carcinoma of the breast
por: Xiao, Meng, et al.
Publicado: (2017)

ZNF703 promotes triple-negative breast cancer cells through cell-cycle signaling and associated with poor prognosis
por: Zhang, Xi, et al.
Publicado: (2022)

CCNE1 amplification is associated with poor prognosis in patients with triple negative breast cancer
por: Zhao, Zi-Ming, et al.
Publicado: (2019)

The different outcomes between breast-conserving surgery and mastectomy in triple-negative breast cancer: a population-based study from the SEER 18 database
por: Chen, Qing-Xia, et al.
Publicado: (2016)

Natural killer cell-related prognostic risk model predicts prognosis and treatment outcomes in triple-negative breast cancer
por: Liu, Zundong, et al.
Publicado: (2023)

ALDH1A1 mRNA expression in association with prognosis of triple-negative breast cancer
por: Liu, Yan, et al.
Publicado: (2015)

CHST9 rs1436904 genetic variant contributes to prognosis of triple-negative breast cancer
por: Yuan, Jupeng, et al.
Publicado: (2017)

Analysis of CK5/6 and EGFR and Its Effect on Prognosis of Triple Negative Breast Cancer
por: Wang, Zhen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b8fptdsu0h6et0jndkok5aa9u3